March Quarter Update & Positive FY26 Guidance

Summary by 6ix AI

IDT Australia Limited has released its March quarter update and provided positive guidance for the fiscal year ahead, indicating a strong finish to the year despite some challenges in the previous quarter. The company expects a significant improvement in earnings, with a forecasted narrowing of EBITDA losses compared to the previous year, driven by strategic realignment and new partnerships. IDT has been designated as a Preferred Vendor by Sanofi, which may enhance its business opportunities, particularly in the specialty pharmaceuticals sector. The update highlights the recommissioning of facilities that are expected to improve profitability and support growth in the coming year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries